| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Clinical Neuroscience Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland 20892; 2 Department of Physiology, Göteborg University, Göteborg, S-413 45 Sweden; and 3 Department of Internal Medicine, St. Radboud University Hospital, Nijmegen, 6523GA The Netherlands
Spillover of norepinephrine (NE) into plasma is used frequently as an index of NE release and therefore of sympathetic nerve activity. An important limitation of NE spillover is that it reflects not only release but also uptake processes that intervene before the transmitter reaches the circulation. To overcome this limitation, we developed a method for estimating NE release based on measurements of the specific activities of [3H]NE in plasma and interstitial fluid during intravenous infusion of [3H]NE. We applied this method to examine relationships among NE release, tissue uptake, and spillover in the human heart, kidneys, and forearm. The sum of uptake and spillover of released NE provided an estimate of NE release into the interstitial fluid. In the kidneys, NE release averaged three times NE spillover, in skeletal muscle, 12 times NE spillover, and in the heart, >20 times NE spillover. Thus NE release greatly and variably exceeds NE spillover from these organs, so that assessing regional sympathetic function requires an understanding of the relationship of NE spillover to NE release.
catecholamines; normetanephrine; metanephrine; kinetics; sympathetic nervous system
This article has been cited by other articles:
|
|
 |
|
  E. A. Wehrwein, L. M. Parker, A. A. Wright, J. M. Spitsbergen, M. Novotny, D. Babankova, G. M. Swain, B. A. Habecker, and D. L. Kreulen Cardiac norepinephrine transporter protein expression is inversely correlated to chamber norepinephrine content Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2008; 295(3): R857 - R863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Xing, S. Koba, V. Kehoe, Z. Gao, K. Rice, N. King, L. Sinoway, and J. Li Interstitial norepinephrine concentrations in skeletal muscle of ischemic heart failure Am J Physiol Heart Circ Physiol, August 1, 2007; 293(2): H1190 - H1195. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. M. Grossman, O. A. Linares, M. A. Supiano, H. Oral, R. H. Mehta, and M. R. Starling Cardiac-specific norepinephrine mass transport and its relationship to left ventricular size and systolic performance Am J Physiol Heart Circ Physiol, August 1, 2004; 287(2): H878 - H888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Lameris, A. H. van den Meiracker, F. Boomsma, G. Alberts, S. de Zeeuw, D. J. Duncker, P. D. Verdouw, and A. J. M. I.'t Veld Catecholamine handling in the porcine heart: a microdialysis approach Am J Physiol Heart Circ Physiol, October 1, 1999; 277(4): H1562 - H1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Neri Serneri, M. Boddi, P. A. Modesti, I. Cecioni, M. Coppo, L. Padeletti, A. Michelucci, A. Colella, and G. Galanti Increased Cardiac Sympathetic Activity and Insulin-Like Growth Factor-I Formation Are Associated With Physiological Hypertrophy in Athletes Circ. Res., November 23, 2001; 89(11): 977 - 982. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
